简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2020-12-10 15:53 PMC Organometallix Continues Expansion
2020-12-10 15:50 C3.ai Announces COVID-19 Grand Challenge Winners
2020-12-10 10:02 Seoul Viosys’ Violeds Technology for Escalator Handrail Sterilization Solutions
2020-12-10 09:57 Takeda Presents Real-World Evidence at ASH 2020, Demonstrating Its Long-Standing Commitment to Personalizing Treatments for Rare Bleeding Disorders
2020-12-10 09:43 EAG Laboratories Announces Latest Advancement in Transmission Electron Microscopy
2020-12-09 18:01 Boehringer Ingelheim to Acquire Labor Dr. Merk & Kollegen to Strengthen its Next Generation Cancer Immunology Program
2020-12-09 16:32 rf IDEAS Announces Mobile Credential Partnership With Datasec
2020-12-09 15:20 Xlear Submits COVID-19 Pre-Emergency Use Authorization Request with FDA Regarding Use of Xlear Nasal Spray to Help in Combating SARS-CoV-2
2020-12-08 20:00 SciNeuro Pharmaceuticals Launches to Bring Innovative Treatments for CNS Diseases
2020-12-08 15:16 Takeda Announces Approval of TAKHZYRO® (lanadelumab) subcutaneous injection in China for the Treatment of Hereditary Angioedema
2020-12-08 14:39 UVD Robots Wins EU Contract to Deploy 200 Robots in Hospitals Across Europe
2020-12-08 10:04 PPD Recognized as a Best Place to Work in Greater China
2020-12-08 09:55 Philip Morris International Announces U.S. Food and Drug Administration Authorization of IQOS 3 for Sale in the United States
2020-12-08 09:53 Boehringer Ingelheim Collaborates with Proxygen to Explore Molecular Glue Degraders - a Novel Approach to Fight Cancer
2020-12-07 15:58 GenesisCare Clinical CRO Adopts Veeva Vault Clinical Applications to Accelerate and Scale Studies Globally
2020-12-07 15:55 Rhizen Pharmaceuticals SA Announces Presentation of the Interim Results of the Phase I/II study of Tenalisib (RP6530) in Combination with Romidepsin in Relapsed/Refractory T-cell Lymphoma at American Society of Hematology (ASH) annual meeting, 2020
2020-12-07 09:51 New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint
2020-12-04 16:21 Clover Biopharmaceuticals Announces Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates
2020-12-04 16:12 Shape Therapeutics Unveils AAVid™ Capsid Discovery Platform and Identification of Novel Tissue-Specific AAV Variants, Solving a Fundamental Delivery Challenge in Gene Therapy
2020-12-03 16:20 PMI Commits to Disability Inclusion by Joining The Valuable 500

Business Wire Weibo

Press Releases

Latest Releases